Contribution: Industrial Research Assistance Program – Contributions to Firms
Virica Biotech Inc.
$354,200.00
UK Multisector - BioM - LV Production Kit: Development of GMP lentiviral production kit with optimized upstream and downstream processes.
EF 2025-26 · 2025-09-01
Résumé
As part of the international consortium project “UK Multisector – BioM - LV Production Kit: Development of GMP lentiviral production kit with optimized upstream and downstream processes” this project will develop an end-to-end and off-the-shelf GMP enabled lentivirus manufacturing kit. The current standard in lentivirus manufacturing is inefficient and delivers low yields, leading to elevated manufacturing costs and less accessible therapeutics. This kit will be the first of its kind, integrating innovative upstream and downstream technologies that have been demonstrated to significantly enhance both upstream manufacturing yields and downstream processing recovery and contributing to the greater accessibility of ex-vivo gene therapy.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Ottawa|Ottawa, Ontario, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
721336089
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2027-02-28
Agreement Number
1034570
Agreement Start Date
2025-09-01
Agreement Title
UK Multisector - BioM - LV Production Kit: Development of GMP lentiviral production kit with optimized upstream and downstream processes.
Agreement Title (French)
UK Multisector - BioM - Trousse de production LV : Développement d’une trousse de production de lentiviraux GMP avec des processus optimisés en amont et en aval.
Agreement Type
Contribution
Agreement Value
$354,200.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
As part of the international consortium project “UK Multisector – BioM - LV Production Kit: Development of GMP lentiviral production kit with optimized upstream and downstream processes” this project will develop an end-to-end and off-the-shelf GMP enabled lentivirus manufacturing kit. The current standard in lentivirus manufacturing is inefficient and delivers low yields, leading to elevated manufacturing costs and less accessible therapeutics. This kit will be the first of its kind, integrating innovative upstream and downstream technologies that have been demonstrated to significantly enhance both upstream manufacturing yields and downstream processing recovery and contributing to the greater accessibility of ex-vivo gene therapy.
Description (French)
Dans le cadre du projet de consortium international «UK Multisector - BioM - LV Production Kit : Development of GMP lentiviral production kit with optimized upstream and downstream processes», ce projet développera une trousse de fabrication de lentivirus de bout en bout et prêt à l’emploi, conforme aux BPF. La norme actuelle de fabrication de lentivirus est inefficace et donne de faibles rendements, ce qui a pour perspective des coûts de fabrication élevés et des produits thérapeutiques moins accessibles. Cette trousse sera la première du genre, intégrant des technologies innovantes en amont et en aval dont il a été démontré qu’elles amélioraient considérablement les rendements de la fabrication en amont et la récupération du traitement en aval, contribuant ainsi à une plus grande accessibilité de la thérapie génique ex-vivo.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ottawa Centre
Federal Riding (French)
Ottawa-Centre
Federal Riding Number
35075
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
721336089
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Virica Biotech Inc.
Recipient Operating Name
Virica Biotech
Recipient Postal Code
K1Z 5N4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2025-2026-Q2-1034570
